Changes in Heart Rhythms Associated With Antipsychotic Drug Treatment

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

September 30, 2008

Conditions
SchizophreniaSchizoaffective DisorderBipolar Disorder
Interventions
DEVICE

24 Holter Monitor Recording

"All subjects will be fitted with a device to obtain 24-hour Holter EKG continuous recordings of bipolar leads C5C5R. They will also receive a standard 12-lead EKG recording prior to the placement of the Holter device. The subjects will be asked to keep a diary during the course of the 24 hours to record information such as wake and sleep times and symptoms such as shortness of breath, heart palpitations, lightheadedness, etc.~From each recording, 12 sets of 10 consecutive QRS epochs, plus QRS samplings obtained during sleep will be analyzed by a cardiologist blind to the medication status of subjects."

Trial Locations (1)

37212-8645

Vanderbilt Psychiatric Hospital, Nashville

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Vanderbilt University

OTHER

NCT00538122 - Changes in Heart Rhythms Associated With Antipsychotic Drug Treatment | Biotech Hunter | Biotech Hunter